NeuBase Therapeutics Announces Agreements for $9 Million Financing
March 11, 2019 07:00 ET | NeuBase Therapeutics, Inc.
PITTBURGH, Pa., March 11, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (“NeuBase”), a biotechnology company developing next generation antisense therapies to address rare genetic diseases,...
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of OHR Pharmaceutical, Inc. (OHRP) on Behalf of Stockholders and Encourages OHRP Investors to Contact the Firm
January 04, 2019 18:56 ET | Bragar Eagel & Squire
NEW YORK, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of OHR Pharmaceutical, Inc. (NASDAQ: OHRP) on behalf of...